Life ScienceCompany
Sinclair Pharmaceuticals M&A Summary
Sinclair Pharmaceuticals has acquired 3 companies of its own, including 1 in the last 5 years. A total of 2 acquisitions came from private equity firms.
Sinclair Pharmaceuticals’ largest acquisition to date was in 2006, when it acquired Ashbourne Pharmaceuticals for $2M. Sinclair Pharmaceuticals has acquired in 2 different US states, and 2 countries. The Company’s most targeted sectors include medical products (67%) and life science (34%).
Sinclair Pharmaceuticals Ownership
Who owns Sinclair Pharmaceuticals?
Sinclair Pharmaceuticals is owned by Huadong Medicine. It was acquired on November 19, 2018.
Sinclair Pharmaceuticals Business Overview
Where is Sinclair Pharmaceuticals headquartered?
Sinclair Pharmaceuticals is headquartered in London, United Kingdom.
What sector is Sinclair Pharmaceuticals in?
Sinclair Pharmaceuticals is a life science company.
M&A Summary
-
M&A Total Activity3
- M&A Buy Activity3
- Total Sectors Invested 2
- Total Countries Invested 2
- M&A Buy/Sell Connections 2
Unlimited Searches
